Healthcare News

Browse the latest Healthcare news, including Healthcare Providers, Medical Equipment, Medical Supplies and Services, Biotechnology and Pharmaceuticals, and Cannabis industries. Use the menu or navigation tiles to get to specific industries within each sector.

January 22, 2026 16:05 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

SAN DIEGO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating...
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
January 22, 2026 16:00 ET | Source: Arcutis Biotherapeutics, Inc.

Arcutis to Report Fourth Quarter and Full Year 2025 Financial Results and Present at Upcoming Investor Conference

Fourth quarter and full year 2025 investor conference call scheduled for February 25, 2026 at 4:30 p.m. ETArcutis management to present at the Guggenheim Emerging Outlook: Biotech Summit on February...
January 22, 2026 14:30 ET | Source: River Oaks Treatment Center

River Oaks Treatment Center Appoints New Clinical Director Amid Expansion of Mental Health Services

River Oaks Treatment Center has appointed Brianna Hardcastle, LCSW, as its new Clinical Director as it expands its primary mental health services.
January 22, 2026 13:42 ET | Source: Psyence Biomedical Ltd.

Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that it adjourned its annual and special meeting of shareholders...
January 22, 2026 12:00 ET | Source: Amoeba

Medalha d’ouro no SIVAL, Amoéba apresenta suas ambições para sua solução de biocontrolo

Chassieu, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Medalha d’ouro no SIVAL, Amoéba apresenta suas ambições para sua solução de biocontrolo Chassieu (França), 22 de janeiro 2026 – 18h00 - Amoéba...
January 22, 2026 12:00 ET | Source: Amoeba

Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution

Chassieu, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Chassieu (France), 20 January 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural...
January 22, 2026 12:00 ET | Source: 4D Path

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

4D Path to participate as exploratory biomarker collaborator in Phase II DAD-IO clinical study (NCT04724018) led by DFCI and supported by Gilead Sciences
January 22, 2026 10:03 ET | Source: LifeLabs

LifeLabs Opens New Uptown New Westminster Patient Service Centre, Enhancing Access to Community-Based Diagnostic Care

New Westminster, BC, Jan. 22, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic services, has officially opened a new Patient Service Centre (PSC) in Uptown New...
January 22, 2026 09:28 ET | Source: Tilray Brands, Inc.

Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique

NEW YORK et SAVONE, Italie, 22 janv. 2026 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis...